Home/Filings/4/0001140361-16-055904
4//SEC Filing

Asterias Biotherapeutics, Inc. 4

Accession 0001140361-16-055904

CIK 0001572552operating

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 9:33 PM ET

Size

7.1 KB

Accession

0001140361-16-055904

Insider Transaction Report

Form 4
Period: 2016-02-28
Cartt Stephen LaHue
DirectorPresident and CEO
Transactions
  • Award

    Stock Options (right to buy)

    2016-02-28+1,000,0001,000,000 total
    Exercise: $3.64From: 2016-02-28Exp: 2026-02-28Common Stock (1,000,000 underlying)
  • Award

    Common Stock

    2016-02-28+200,000200,000 total
Footnotes (2)
  • [F1]Such shares of restricted common stock were granted by the Board and vest in two equal installments on August 31, 2016 and February 28, 2017, conditioned on the reporting person's continued employment, as detailed in his employment agreement.
  • [F2]The stock options vest in 48 equal monthly installments commencing on March 31, 2016, conditioned on the reporting person's continued employment, as detailed in his employment agreement.

Documents

1 file

Issuer

Asterias Biotherapeutics, Inc.

CIK 0001572552

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001572552

Filing Metadata

Form type
4
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 9:33 PM ET
Size
7.1 KB